326 related articles for article (PubMed ID: 15037669)
1. Rapid treatment of "wearing off" in Parkinson's disease.
Swope DM
Neurology; 2004 Mar; 62(6 Suppl 4):S27-31. PubMed ID: 15037669
[TBL] [Abstract][Full Text] [Related]
2. A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease.
Chen JJ; Obering C
Clin Ther; 2005 Nov; 27(11):1710-24. PubMed ID: 16368444
[TBL] [Abstract][Full Text] [Related]
3. Medical management of levodopa-associated motor complications in patients with Parkinson's disease.
Jankovic J; Stacy M
CNS Drugs; 2007; 21(8):677-92. PubMed ID: 17630819
[TBL] [Abstract][Full Text] [Related]
4. Intranasal apomorphine rescue therapy for parkinsonian "off" periods.
Dewey RB; Maraganore DM; Ahlskog JE; Matsumoto JY
Clin Neuropharmacol; 1996 Jun; 19(3):193-201. PubMed ID: 8726538
[TBL] [Abstract][Full Text] [Related]
5. Other pharmacological treatments for motor complications and dyskinesias.
Waters C
Mov Disord; 2005; 20 Suppl 11():S38-44. PubMed ID: 15822104
[TBL] [Abstract][Full Text] [Related]
6. Practical considerations in the use of apomorphine injectable.
Bowron A
Neurology; 2004 Mar; 62(6 Suppl 4):S32-6. PubMed ID: 15037670
[TBL] [Abstract][Full Text] [Related]
7. Treatment of levodopa-induced motor complications.
Stocchi F; Tagliati M; Olanow CW
Mov Disord; 2008; 23 Suppl 3():S599-612. PubMed ID: 18781681
[TBL] [Abstract][Full Text] [Related]
8. Drugs for Parkinson's disease.
Treat Guidel Med Lett; 2013 Nov; 11(135):101-6. PubMed ID: 24165688
[TBL] [Abstract][Full Text] [Related]
9. On demand therapy for Parkinson's disease patients: Opportunities and choices.
Hauser RA; LeWitt PA; Comella CL
Postgrad Med; 2021 Sep; 133(7):721-727. PubMed ID: 34082655
[TBL] [Abstract][Full Text] [Related]
10. Levodopa-induced dyskinesias and continuous subcutaneous infusions of apomorphine: results of a two-year, prospective follow-up.
Kanovský P; Kubová D; Bareš M; Hortová H; Streitová H; Rektor I; Znojil V
Mov Disord; 2002 Jan; 17(1):188-91. PubMed ID: 11835461
[TBL] [Abstract][Full Text] [Related]
11. Role of the pharmacist in the effective management of wearing-off in Parkinson's disease.
Simonson W; Hauser RA; Schapira AH
Ann Pharmacother; 2007 Nov; 41(11):1842-9. PubMed ID: 17878397
[TBL] [Abstract][Full Text] [Related]
12. Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease.
Colzi A; Turner K; Lees AJ
J Neurol Neurosurg Psychiatry; 1998 May; 64(5):573-6. PubMed ID: 9598668
[TBL] [Abstract][Full Text] [Related]
13. Current management of motor fluctuations in patients with advanced Parkinson's disease treated chronically with levodopa.
Melamed E; Zoldan J; Galili-Mosberg R; Ziv I; Djaldetti R
J Neural Transm Suppl; 1999; 56():173-83. PubMed ID: 10370911
[TBL] [Abstract][Full Text] [Related]
14. Parkinson's disease--levodopa complications.
King DB
Can J Neurol Sci; 1999 Aug; 26 Suppl 2():S13-20. PubMed ID: 10451755
[TBL] [Abstract][Full Text] [Related]
15. Levodopa-related wearing-off in Parkinson's disease: identification and management.
Pahwa R; Lyons KE
Curr Med Res Opin; 2009 Apr; 25(4):841-9. PubMed ID: 19228103
[TBL] [Abstract][Full Text] [Related]
16. Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged-release.
Rascol O
Eur J Neurol; 2011 Mar; 18 Suppl 1():3-10. PubMed ID: 21255197
[TBL] [Abstract][Full Text] [Related]
17. Update on apomorphine for the rapid treatment of hypomobility ("off") episodes in Parkinson's disease.
Obering CD; Chen JJ; Swope DM
Pharmacotherapy; 2006 Jun; 26(6):840-52. PubMed ID: 16716137
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.
Deleu D; Hanssens Y; Northway MG
Drugs Aging; 2004; 21(11):687-709. PubMed ID: 15323576
[TBL] [Abstract][Full Text] [Related]
19. New dopaminergic therapies for PD motor complications.
Larson D; Simuni T
Neuropharmacology; 2022 Feb; 204():108869. PubMed ID: 34742740
[TBL] [Abstract][Full Text] [Related]
20. High-dose ropinirole in advanced Parkinson's disease with severe dyskinesias.
Cristina S; Zangaglia R; Mancini F; Martignoni E; Nappi G; Pacchetti C
Clin Neuropharmacol; 2003; 26(3):146-50. PubMed ID: 12782917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]